Chemours Reports Mixed Q2 2026 Results Amid Pricing Gains and Volume Declines
Event summary
- Chemours reported Q2 2026 net sales of $1.6 billion, flat year-over-year, with a net loss of $274 million, narrower than the prior-year quarter's $380 million loss.
- Adjusted EBITDA declined 5% to $247 million, while free cash flow improved 128% year-over-year to $114 million.
- Titanium Technologies saw a 1% sales increase driven by global pricing actions, while Advanced Performance Materials faced a 6% decline due to volume reductions from the SPS Capstone™ line closure.
- The company announced an additional global TiO2 price increase effective June 1, 2026, contributing to a 5% year-to-date price increase in net sales.
The big picture
Chemours' Q2 results reflect a mixed performance, with pricing actions offsetting volume declines across key segments. The company's focus on high-value specialty products in APM and strategic pricing in TT underscores its efforts to navigate a dynamic macroeconomic environment. However, operational challenges and legacy litigation remain critical factors in its Pathway to Thrive strategy.
What we're watching
- Pricing Strategy Impact
- How Chemours' recent TiO2 price increases will affect margins and market share in the face of volume declines.
- Operational Recovery
- Whether APM can sustain momentum in high-value specialty products amid ongoing operational challenges.
- Debt Reduction Progress
- The pace at which Chemours reduces its net leverage ratio toward the target of below 3x by year-end.
Related topics